Literature DB >> 25653284

Processing by convertases is required for glypican-3-induced inhibition of Hedgehog signaling.

Mariana Capurro1, Wen Shi1, Tomomi Izumikawa1, Hiroshi Kitagawa2, Jorge Filmus3.   

Abstract

Glypican-3 (GPC3) is one of the six members of the mammalian glypican family. We have previously reported that GPC3 inhibits Hedgehog (Hh) signaling by competing with Patched (Ptc) for Hh binding. We also showed that GPC3 binds with high affinity to Hh through its core protein, but that it does not interact with Ptc. Several members of the glypican family, including GPC3, are subjected to an endoproteolytic cleavage by the furin-like convertase family of endoproteases. Surprisingly, however, we have found that a mutant GPC3 that cannot be processed by convertases is as potent as wild-type GPC3 in stimulating Wnt activity in hepatocellular carcinoma cell lines and 293T cells and in promoting hepatocellular carcinoma growth. In this study, we show that processing by convertases is essential for GPC3-induced inhibition of Hh signaling. Moreover, we show that a convertase-resistant GPC3 stimulates Hh signaling by increasing the binding of this growth factor to Ptc. Consistent with this, we show that the convertase-resistant mutant binds to both Hh and Ptc through its heparan sulfate (HS) chains. Unexpectedly, we found that the mutant core protein does not bind to Hh. We also report that the convertase-resistant mutant GPC3 carries HS chains with a significantly higher degree of sulfation than those of wild-type GPC3. We propose that the structural changes generated by the lack of cleavage determine a change in the sulfation of the HS chains and that these hypersulfated chains mediate the interaction of the mutant GPC3 with Ptc.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Convertase; Glycosaminoglycan; Glypican-3; Hedgehog Signaling Pathway; Heparan Sulfate; Proteoglycan

Mesh:

Substances:

Year:  2015        PMID: 25653284      PMCID: PMC4367263          DOI: 10.1074/jbc.M114.612705

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Developmental roles of the glypicans.

Authors:  B De Cat; G David
Journal:  Semin Cell Dev Biol       Date:  2001-04       Impact factor: 7.727

2.  The loss of glypican-3 induces alterations in Wnt signaling.

Authors:  Howard H Song; Wen Shi; Yun-Yan Xiang; Jorge Filmus
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

3.  Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.

Authors:  Mariana I Capurro; Yun-Yan Xiang; Corrinne Lobe; Jorge Filmus
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

4.  Processing by convertases is not required for glypican-3-induced stimulation of hepatocellular carcinoma growth.

Authors:  Mariana I Capurro; Wen Shi; Shaifali Sandal; Jorge Filmus
Journal:  J Biol Chem       Date:  2005-10-14       Impact factor: 5.157

5.  Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding.

Authors:  Mariana I Capurro; Ping Xu; Wen Shi; Fuchuan Li; Angela Jia; Jorge Filmus
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

6.  Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.

Authors:  Wei Gao; Heungnam Kim; Mingqian Feng; Yen Phung; Charles P Xavier; Jeffrey S Rubin; Mitchell Ho
Journal:  Hepatology       Date:  2014-06-18       Impact factor: 17.425

7.  Dally regulates Dpp morphogen gradient formation by stabilizing Dpp on the cell surface.

Authors:  Takuya Akiyama; Keisuke Kamimura; Cyndy Firkus; Satomi Takeo; Osamu Shimmi; Hiroshi Nakato
Journal:  Dev Biol       Date:  2007-11-01       Impact factor: 3.582

8.  Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.

Authors:  D F Cano-Gauci; H H Song; H Yang; C McKerlie; B Choo; W Shi; R Pullano; T D Piscione; S Grisaru; S Soon; L Sedlackova; A K Tanswell; T W Mak; H Yeger; G A Lockwood; N D Rosenblum; J Filmus
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

9.  Patched1 regulates hedgehog signaling at the primary cilium.

Authors:  Rajat Rohatgi; Ljiljana Milenkovic; Matthew P Scott
Journal:  Science       Date:  2007-07-20       Impact factor: 47.728

Review 10.  Glypicans.

Authors:  Jorge Filmus; Mariana Capurro; Jonathan Rast
Journal:  Genome Biol       Date:  2008-05-22       Impact factor: 13.583

View more
  10 in total

1.  Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma.

Authors:  Mauro Montalbano; Cristiana Rastellini; Joshua T McGuire; Janika Prajapati; Ali Shirafkan; Renza Vento; Luca Cicalese
Journal:  Cell Oncol (Dordr)       Date:  2017-12-04       Impact factor: 6.730

Review 2.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

3.  Hedgehog pathway modulation by glypican 3-conjugated heparan sulfate.

Authors:  Yulu Cherry Liu; Bradley M Wierbowski; Adrian Salic
Journal:  J Cell Sci       Date:  2022-03-17       Impact factor: 5.285

Review 4.  Proteolysis: a key post-translational modification regulating proteoglycans.

Authors:  Timothy J Mead; Sumit Bhutada; Daniel R Martin; Suneel S Apte
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

Review 5.  Proteoglycan form and function: A comprehensive nomenclature of proteoglycans.

Authors:  Renato V Iozzo; Liliana Schaefer
Journal:  Matrix Biol       Date:  2015-02-18       Impact factor: 11.583

Review 6.  Development of Glypican-3 Targeting Immunotoxins for the Treatment of Liver Cancer: An Update.

Authors:  Bryan D Fleming; Mitchell Ho
Journal:  Biomolecules       Date:  2020-06-20

Review 7.  The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer.

Authors:  Aarti Kolluri; Mitchell Ho
Journal:  Front Oncol       Date:  2019-08-02       Impact factor: 6.244

8.  Sulf2a controls Shh-dependent neural fate specification in the developing spinal cord.

Authors:  Cathy Danesin; Romain Darche-Gabinaud; Nathalie Escalas; Vanessa Bouguetoch; Philippe Cochard; Amir Al Oustah; David Ohayon; Bruno Glise; Cathy Soula
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

9.  Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.

Authors:  Xue Yan Cui; Geir Erland Tjønnfjord; Sandip M Kanse; Anders Erik Astrup Dahm; Nina Iversen; Christiane Filion Myklebust; Ling Sun; Zhong Xing Jiang; Thor Ueland; James J Campbell; Mitchell Ho; Per Morten Sandset
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

10.  Assembling custom side chains on proteoglycans to interrogate their function in living cells.

Authors:  Wenshuang Wang; Naihan Han; Yingying Xu; Yunxue Zhao; Liran Shi; Jorge Filmus; Fuchuan Li
Journal:  Nat Commun       Date:  2020-11-20       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.